Advertisement Dr Reddy's Launches Amlodipine Benazepril Capsules In US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Dr Reddy’s Launches Amlodipine Benazepril Capsules In US

Dr Reddy’s Laboratories has launched Amlodipine benazepril capsules (2.5mg/10mg, 5mg/10mg, 5mg/20mg, 10mg/20mg), a bioequivalent generic version of Lotrel capsules, in the US market on April 23, 2010.

Amlodipine benazepril is indicated for the treatment of hypertension in patients not adequately controlled with either agent and is taken once daily. Dr Reddy’s product is available in bottles of 100 count capsules.

Amlodipine/Benazepril is a combination of 2 blood pressure medicines, an angiotensin-converting enzyme (ACE) inhibitor and a calcium channel blocker. It works by helping your blood vessels relax (dilate) and lower blood pressure.

Earlier, in September 2009, Dr Reddy’s had entered into a patent settlement with Novartis on Amlodipine benazepril stipulating the dismissal of the lawsuits in the US. The FDA granted an approval of Dr Reddy’s ANDA for Amlodipine benazepril on April 15, 2010.